Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease

Table 4

Comparison of lab data between GBA and non-GBA in Kawasaki disease after IVIG therapy.

	Group A (non-GBA, 𝑁=61)	Group B (GBA, 𝑁=16)	𝑃 value
WBC cell (/mm^3)	9849 ± 3693	10662 ± 3923	0.441
Hemoglobin (g/dL)	10.6±1.33	10.4±1.02	0.564
Platelet (×10^4/mm^3)	47.8±16.6	35.4±12.6	0.007*
Neutrophil (%)	40.3±18.2	53.6±24.6	0.018*
Lymphocyte (%)	45.8±18.8	33.2±23.19	0.26
Eosinophil (%)	4.05±5.08	5.02±3.40	0.473
Monocyte (%)	7.40±3.03	6.01±3.21	0.113
C-reactive protein (mg/L)	38.9±36.8	85.7±71.1	0.032*
GOT (U/L)	30.0±7.78	39.7±17.7	0.084
GPT (U/L)	35.7±19.0	68.7±40.5	0.016*

* 𝑃<0.05.